{
 "license": "https://creativecommons.org/licenses/by/4.0/",
 "id": "ifra-p-bmhca",
 "type": "Regulation",
 "version": 1,
 "updated": "2026-09-30",
 "station": 2,
 "confidence": "A",
 "sources": [
  "IFRA-015"
 ],
 "body": "IFRA",
 "name": {
  "value": "IFRA Standard: p-tert-Butyl-α-methylhydrocinnamic aldehyde (p-BMHCA)",
  "evidence": "documented",
  "source": "IFRA-015",
  "where": "docs/sources/IFRA-015-p-bmhca.md:14",
  "quote": "Amendment 49 p-tert-Butyl-α-methylhydrocinnamic aldehyde (p-BMHCA)",
  "confidence": "A"
 },
 "instrument": "IFRA Standard (Amendment 49)",
 "restriction_type": {
  "value": "RESTRICTION / PROHIBITION",
  "evidence": "documented",
  "source": "IFRA-015",
  "where": "docs/sources/IFRA-015-p-bmhca.md:26",
  "quote": "RECOMMENDATION: RESTRICTION / PROHIBITION",
  "confidence": "A"
 },
 "property": {
  "value": "dermal sensitization and systemic toxicity",
  "evidence": "documented",
  "source": "IFRA-015",
  "where": "docs/sources/IFRA-015-p-bmhca.md:32",
  "quote": "INTRINSIC PROPERTY DRIVING RISK MANAGEMENT: DERMAL SENSITIZATION AND SYSTEMIC TOXICITY",
  "confidence": "A"
 },
 "summary": {
  "value": "A restriction by maximum concentration in the finished product, per product category, with a prohibition for lipsticks and oral care products (IFRA Categories 1 and 6).",
  "evidence": "documented",
  "source": "IFRA-015",
  "where": "docs/sources/IFRA-015-p-bmhca.md:29",
  "quote": "FRAGRANCE INGREDIENT PROHIBITION: p-tert-Butyl-α-methylhydrocinnamic aldehyde (p- BMHCA) should not be used for any finished product application included under IFRA Categories 1 and 6 (lipsticks and oral care products).",
  "confidence": "A"
 },
 "dates": [
  {
   "what": "published (IFRA Amendment 49)",
   "value": "2020 (Amendment 49)",
   "evidence": "documented",
   "source": "IFRA-015",
   "where": "docs/sources/IFRA-015-p-bmhca.md:23",
   "quote": "History: Publication date: 2020 (Amendment 49)",
   "confidence": "A"
  }
 ],
 "applies_to": [
  {
   "molecule": "p-bmhca",
   "entry": "p-tert-Butyl-α-methylhydrocinnamic aldehyde (p-BMHCA), CAS 80-54-6",
   "evidence": "documented",
   "source": "IFRA-015",
   "where": "docs/sources/IFRA-015-p-bmhca.md:20",
   "quote": "CAS-No.: 80-54-6",
   "confidence": "A"
  }
 ],
 "as_of": "2026-09-30",
 "disclaimer": "An educational summary of a public standard, as of 2026-09-30; not compliance advice. Read the current text at the source.",
 "url": "https://d3t14p1xronwr0.cloudfront.net/docs/standards/IFRA_STD_015.pdf",
 "legislation_identifier": null,
 "amends": [],
 "amended_by": [],
 "media": [],
 "links": {
  "essay": "/library#ifra-database"
 },
 "copy": {
  "lede": "IFRA’s Standard on p-BMHCA is a restriction with a prohibition for two product categories: the industry’s own rule, not law.",
  "body": [
   "The property it manages is dermal sensitization and systemic toxicity. This page names the kind of limit; the figures per product category are at the source, which is the text to read."
  ]
 }
}